[HTML][HTML] Post-COVID-19 Symptoms in Adults with Asthma—Systematic Review

M Kaszuba, N Madej, R Pilinski, A Sliwka - Biomedicines, 2023 - mdpi.com
Background: Research on the longer-term sequelae of COVID-19 in patients with asthma is
limited. Objective: To assess the frequency and severity of long-term symptoms of COVID-19 …

Pediatric asthma exacerbation and COVID-19 pandemic: Impacts, challenges, and future considerations

S Khojasteh-Kaffash, P Parhizkar Roudsari… - Journal of …, 2024 - Taylor & Francis
Objective Asthma, a common disease among children and adolescents, poses a great
health risk when ignored; therefore, a thorough follow-up to prevent exacerbations is …

Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir as treatments for COVID-19 in patients at high risk

D Paraskevis, M Gkova, K Mellou… - The Journal of …, 2023 - academic.oup.com
Background Using a retrospective cohort study design, we aimed to evaluate the
effectiveness of molnupiravir and nirmatrelvir/ritonavir in patients with SARS-CoV-2 who …

[HTML][HTML] Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity

H Zhang, K Xue, W Li, X Yang, Y Gou, X Su… - Nature …, 2024 - nature.com
Asthma exacerbations caused by respiratory viral infections are a serious global health
problem. Impaired antiviral immunity is thought to contribute to the pathogenesis, but the …

Network-based analysis between SARS-CoV-2 receptor ACE2 and common host factors in COVID-19 and asthma: Potential mechanistic insights

Q Yan, XY Lin, CW Peng, WJ Zheng, XH Liu… - … Signal Processing and …, 2024 - Elsevier
ACE2 as a functional receptor for SARS coronavirus plays an important role in COVID-19
infection of the host. Thus, we aimed to explore interaction networks between ACE2 and …

[HTML][HTML] Integrating AI/ML models for patient stratification leveraging omics dataset and clinical biomarkers from COVID-19 patients: A promising approach to …

B Bello, YN Bundey, R Bhave, M Khotimchenko… - International Journal of …, 2023 - mdpi.com
The COVID-19 pandemic has presented an unprecedented challenge to the healthcare
system. Identifying the genomics and clinical biomarkers for effective patient stratification …

Differences in mortality among patients with asthma and COPD hospitalized with COVID-19

Y Liu, H Rajeevan, M Simonov, S Lee… - The Journal of Allergy …, 2023 - Elsevier
Background It remains unclear whether patients with asthma and/or chronic obstructive
pulmonary disease (COPD) are at increased risk for severe coronavirus disease 2019 …

Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 community, highly vaccinated patients with high risk for severe disease: evidence …

D Paraskevis, M Gkova, K Mellou, G Gerolymatos… - medRxiv, 2023 - medrxiv.org
Besides the significant benefits of vaccination against COVID-19, the risk of severe disease
and death from COVID-19 among highly vulnerable populations remains of concern …

[HTML][HTML] COVID-19 vaccine intentions and attitudes in Black American emerging adults with asthma

AL Hall, P Movva, R Dailey, W Gibson-Scipio… - BMC Public Health, 2024 - Springer
Abstract Background Emerging adults (aged 18–29) are less likely to receive the COVID-19
vaccine than any other adult age group. Black Americans are less likely than non-Hispanic …

[HTML][HTML] Association between allergic conditions and COVID-19 susceptibility and outcomes

C Chen, X Song, DJ Murdock, A Marcus… - Annals of Allergy …, 2024 - Elsevier
Background The relationship between underlying type 2 inflammation and immune
response to COVID-19 is unclear. Objective To assess the relationships between allergic …